XML 9 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Real estate assets:    
Land [1] $ 592,056 $ 588,153
Buildings and improvements [1] 1,512,377 1,505,232
Real estate assets [1] 2,104,433 2,093,385
Accumulated depreciation [1] (303,946) (283,785)
Net investment in real estate assets [1] 1,800,487 1,809,600
Held-for-sale [1]   56,075
Developments in progress [1] 6,381 5,817
Net investment in real estate assets [1] 1,806,868 1,871,492
Cash and cash equivalents [1] 29,822 40,791
Restricted cash [1] 93,325 112,938
Available-for-sale securities - at fair value (amortized cost of $246,216 and $242,881 as of March 31, 2025 and December 31, 2024, respectively) [1] 246,290 243,148
Receivables:    
Tenant [1] 37,876 45,594
Other [1] 2,618 2,356
Investments in unconsolidated affiliates [1] 84,121 83,465
In-place leases, net [1] 167,852 186,561
Intangible lease assets and other assets [1] 155,742 160,846
Total assets [1] 2,624,514 2,747,191
LIABILITIES AND EQUITY    
Mortgage and other indebtedness, net 2,150,562 2,212,680
Accounts payable and accrued liabilities 190,190 221,647
Total liabilities [1] 2,340,752 2,434,327
Shareholders' equity:    
Common stock, $.001 par value, 200,000,000 shares authorized, 30,935,677 and 30,711,227 issued and outstanding as of March 31, 2025 and December 31, 2024, respectively (in each case, excluding 34 treasury shares) 31 31
Additional paid-in capital 694,855 694,566
Accumulated other comprehensive income 307 782
Accumulated deficit (400,167) (371,833)
Total shareholders' equity 295,026 323,546
Noncontrolling interests (11,264) (10,682)
Total equity 283,762 312,864
Total liabilities, redeemable noncontrolling interests and equity $ 2,624,514 $ 2,747,191
[1] As of March 31, 2025, includes $168,625 of assets related to consolidated variable interest entities that can be used only to settle obligations of the consolidated variable interest entities and $208,932 of liabilities of consolidated variable interest entities for which creditors do not have recourse to the general credit of the Company. See Note 8.